Mutations in HIV-1 protease associated with resistance to amprenavir contribute towards phenotypic resistance to lopinavir

被引：0
|
作者：
Parkin, NT [1 ]
Chappey, C [1 ]
Petropoulos, CJ [1 ]
机构：
[1] ViroLogic, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
24
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [31] HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes
    Lisovsky, Irene
    Schader, Susan M.
    Martinez-Cajas, Jorge-Luis
    Oliveira, Maureen
    Moisi, Daniela
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2878 - 2885
  • [32] Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients
    Hasson, H
    Gianotti, N
    Danise, A
    Seminari, E
    Boeri, E
    Nozza, S
    Castagna, A
    Lazzarin, A
    AIDS, 2004, 18 (01) : 123 - 127
  • [33] Molecular mechanisms of HIV-1 protease resistance and resensitization towards lopinavir and saquinavir upon L76V mutation
    Bastys, T.
    Doncheva, N. T.
    Walter, H.
    Kaiser, R.
    Albrecht, M.
    Kalinina, O. V.
    ANTIVIRAL THERAPY, 2014, 19 : A154 - A154
  • [34] Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition
    Mueller, Sandra M.
    Spriewald, Bernd M.
    Bergmann, Silke
    Eismann, Kathrin
    Leykauf, Melanie
    Korn, Klaus
    Walter, Hauke
    Schmidt, Barbara
    Arnold, Marie-Luise
    Harrer, Ellen G.
    Kaiser, Rolf
    Schweitzer, Finja
    Braun, Patrick
    Reuter, Stefan
    Jaeger, Hans
    Wolf, Eva
    Brockmeyer, Norbert H.
    Jansen, Klaus
    Michalik, Claudia
    Harrer, Thomas
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (02) : 109 - 117
  • [35] Analyses of accessory mutations in HIV-1 protease reveal interdependent mechanisms of resistance
    Ragland, D. A.
    Nalam, M. N. L.
    Ozen, A.
    Cai, Y.
    Cao, H.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2014, 19 : A155 - A155
  • [36] Temporal characterization of frequency of drug-resistance associated mutations in the HIV-1 protease and reverse transcriptase
    Ceccherini-Silberstein, F
    Santoro, M
    Svicher, V
    Gori, C
    Zaccarelli, M
    Forbici, F
    d'Arrigo, R
    Trotta, MP
    Bellocchi, MC
    Visco-Comandini, U
    Giannella, S
    Bertoli, A
    Antinori, A
    Perno, CF
    ANTIVIRAL THERAPY, 2004, 9 (04) : U84 - U84
  • [37] Accessory mutations balance the marginal stability of the HIV-1 protease in drug resistance
    Weikl, Thomas R.
    Hemmateenejad, Bahram
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (03) : 476 - 484
  • [38] Phenotypic drug resistance patterns in subtype a HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations
    Eshleman, SH
    Jones, D
    Galovich, J
    Paxinos, EE
    Petropoulos, CJ
    Jackson, JB
    Parkin, N
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 289 - 293
  • [39] HIV-1 protease inhibitors and mechanisms of HIV-1's resistance
    Das, Debananda
    GLOBAL HEALTH & MEDICINE, 2024, 6 (06): : 357 - 362
  • [40] Protease inhibitor resistance in HIV-1 infection
    Resch, W
    Swanstrom, R
    REVIEWS IN MEDICAL MICROBIOLOGY, 2000, 11 (04) : 211 - 221
12345